More articles from News in Depth

CAR T-cell Therapy for Solid Tumors?
Cancer Discovery Oct 2018, DOI: 10.1158/2159-8290.CD-ND2018-008
Better Standards Sought for Predictive Immunotherapy Biomarkers
Cancer Discovery Oct 2018, DOI: 10.1158/2159-8290.CD-ND2018-009
The Quest for Off-the-Shelf CAR T Cells
Cancer Discovery Jul 2018, 8 (7) 787-788; DOI: 10.1158/2159-8290.CD-ND2018-005
Companies Scaling Back IDO1 Inhibitor Trials
Cancer Discovery Jul 2018, 8 (7) OF5; DOI: 10.1158/2159-8290.CD-ND2018-007
Warming “Cold” Melanoma with TLR9 Agonists
Cancer Discovery Jun 2018, 8 (6) 670; DOI: 10.1158/2159-8290.CD-ND2018-004
Q&A: Ned Sharpless on His Vision for NCI
Cancer Discovery Jun 2018, 8 (6) 669; DOI: 10.1158/2159-8290.CD-ND2018-006
STINGing Antitumor Immunity into Action
Cancer Discovery Mar 2018, 8 (3) 259-260; DOI: 10.1158/2159-8290.CD-ND2018-002
Venetoclax Data Prompt Rethink of CLL Therapy
Cancer Discovery Mar 2018, 8 (3) OF5; DOI: 10.1158/2159-8290.CD-ND2018-003
Gut Bacteria Shape Therapeutic Response
Cancer Discovery Feb 2018, 8 (2) 134; DOI: 10.1158/2159-8290.CD-ND2018-001
Checkpoint Inhibitors Spur Changes in Trial Design
Cancer Discovery Nov 2017, 7 (11) 1209-1210; DOI: 10.1158/2159-8290.CD-ND2017-006

Main menu